The JSE closed at a record high on Monday, despite SA's vaccine setback, tracking firmer global markets on hopes that US stimulus aid will be passed soon.

SA’s vaccination plans may need to be revised after new evidence showed on Sunday that AstraZeneca’s vaccine — which is the cornerstone of the first phase of SA’s Covid-19 immunisation strategy — does not protect against mild to moderate disease caused by the new variant detected in SA late last year.  ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now